Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription or Fee Access

No 3s (2013)

Articles

LEChENIE DEPRESSII PRI NEVROLOGIChESKIKh ZABOLEVANIYaKh

Voznesenskaya T.G.

Abstract

This review considers the neurophysiological processes characteristic of depression in different groups of neurological patients. The cause-effect relations between neurological disease and the occurrence of depression are discussed. The issues of pathogenesis, diagnosis, and treatment are described. Approaches to the choice and selection of antidepressant therapy in concomitant psycho-pathological syndromes are recommended.
Pharmateca. 2013;(3s):9-13
pages 9-13 views

LEGKIE I UMERENNYE KOGNITIVNYE NARUShENIYa: KLINIChESKIE PROYaVLENIYa, ETIOLOGIYa, PATOGENEZ, VOZMOZhNOSTI ISPOL'ZOVANIYa NOOTROPNOY TERAPII

Preobrazhenskaya I.S.

Abstract

This article analyzes the prevalence, causes, and the main clinical manifestations of non-dementing cognitive impairments -a syndrome, which is a clinical manifestation of many physical, neurological and psychiatric disorders. The diagnostic approach and the possibility of differential diagnosis are discussed in detail. The basic principles of treatment of mild cognitive disorders are presented; potentials for the use of several classes of drugs with presumable neuroprotective action are also discussed.
Pharmateca. 2013;(3s):14-19
pages 14-19 views

TIKOZNYE RASSTROYSTVA I ROL' PREPARATA AMINOFENILMASLYaNOY KISLOTY V IKh LEChENII

Studenikin V.M., Shelkovskiy V.I., Kuzenkova L.M.

Abstract

The article is dedicated to the problem of tic disorders in children. The definition and classification of tics, analysis of the etiology, pathogenesis, clinical manifestations, principles of diagnosis and treatment of tic disorders in children are presented in detail. Particular attention is paid to the encapsulated form of aminophenyl-butyric acid - Anvifen.
Pharmateca. 2013;(3s):20-24
pages 20-24 views

PREODOLENIE NONKOMPLAENTNOSTI PRI TERAPII KhRONIChESKIKh PSIKhIChESKIKh ZABOLEVANIY

Avedisova A.S.

Abstract

The article considers the complex issues of noncompliance in the treatment of chronic mental illness with an emphasis on the patient's motivation and behavioral aspects. The continuum of behavioral models of treatment compliance - from full failure to abuse - is discussed. The recommendations for overcoming of noncompliance during motivational therapy are presented.
Pharmateca. 2013;(3s):25-30
pages 25-30 views

SINDROM EMOTsIONAL'NOGO VYGORANIYa: KLINIChESKIE VARIANTY

Chutko L.S., Rozhkova A.V., Surushkina S.Y.

Abstract

The article describes the main clinical manifestations of burnout syndrome (BS) and the principles of the approach to the treatment of this disorder. As part of this work, 103 patients with clinical manifestations in age from 25 to 45 years were examined. Leading syndromes characteristic of patients with the BS are described. The complex of measures for the correction of the BS, including both preventive measures and treatment, is presented. The mechanisms of action of basic psychopharmacological agents for the treatment of BS are discussed.
Pharmateca. 2013;(3s):31-33
pages 31-33 views

ShIZOFRENIYa I UPOTREBLENIE PSIKhOAKTIVNYKh VEShchESTV: PODKhODY K DIAGNOSTIKE I VYBORU ANTIPSIKhOTIChESKOY TERAPII

Ivanov M.V., Shipilin M.Y., Yanushko M.G.

Abstract

The use of amphetamine/methamphetamine-type stimulants occurs widely in the population of schizophrenic patients. The article presents an analysis of the pathogenesis, clinical features, and the comparative effectiveness of different antipsychotic treatments of psychosis induced by psychoactive substances in schizophrenic patients. The data on the spectrum of cognitive impairments in schizophrenic patients with substance use compared to patients with schizophrenia without a history of substance use are presented. The data obtained provide more evidence of the similarity of the neurobiological mechanisms of schizophrenia and the effects of use of psychoactive substances. Management of mental disorders induced by amphetamine/methamphetamine-type stimulants remains underinvestigated.
Pharmateca. 2013;(3s):34-38
pages 34-38 views

GOLOVNAYa BOL' I PSIKhIChESKIE RASSTROYSTVA: VZGLYaD NEVROLOGA I PSIKhIATRA

Azimova Y.E., Magomedova A.N.

Abstract

Emotional and affective disorders and some forms of headache have a close relationship. The significance of anxiety and depressive disorders is so great that in the International Classification of Headache Disorders III (2013), the section «Headache associated with mental disorders» has been greatly expanded. This enables making better diagnosis and extends approaches to drug therapy in patients with severe and resistant to treatment forms of headache.
Pharmateca. 2013;(3s):39-44
pages 39-44 views

LEChENIE SINDROMA DEFITsITA VNIMANIYa S GIPERAKTIVNOST'Yu U DETEY

Chutko L.S., Surushkina S.Y.

Abstract

The article describes the main principles of an integrated approach to the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents. The basic forms and variants of the clinical picture are characterized. The principles of the provision of medical and rehabilitation care, psychocorrection approaches and methods of the behavior modification for children are discussed. The main groups of drugs used for the specific treatment of ADHD are presented. The authors paid attention to the need for a detailed diagnostic examination in order to clarify the type, form and variant of the disease.
Pharmateca. 2013;(3s):45-48
pages 45-48 views

DONEPEZIL V LEChENII BOLEZNI AL'TsGEYMERA

Kolykhalov I.V.

Abstract

This report considers the clinical efficacy and safety of one of the leading drug for the correction of central cholinergic deficits in patients with Alzheimer's disease (AD), donepezil (Alzepil, Egis, Hungary), which past two years was used in Russia. Donepezil has shown effectiveness in both cognitive and behavioral correction of disorders in AD patients. Furthermore, donepezil may be included in the scheme of therapy in AD patients with moderate and even severe dementia.
Pharmateca. 2013;(3s):49-52
pages 49-52 views

OSTEOARTROZ I OSTEOARTRIT - OT NOVYKh VZGLYaDOV V PATOGENEZE K NOVOMU NAZVANIYu

Khitrov N.A.

Abstract

The article presents the data on the pathogenesis and clinical manifestation of osteoarthrosis (OA); underlying mechanisms of development of OA include both inflammatory processes and degeneration of joint tissues. The features of synovitis in OA according to data of ultrasound examination are presented. The treatment of OA of the knee in the acute phase using meloxicam and Compligam V is described. Good clinical results indicating reduction of pain and swelling, increase of range of motion, and good tolerability of the drug were achieved.
Pharmateca. 2013;(3s):53-58
pages 53-58 views

EFFEKTIVNOST' SOChETANNOY ELEKTROSUDOROZhNOY I NEYROLEPTIChESKOY TERAPII V PREODOLENII TERAPEVTIChESKOY REZISTENTNOSTI U BOL'NYKh ShIZOFRENIEY

Petrova N.N., Ivanov M.V., Kaleva M.A., Chomskaya V.M.

Abstract

On the example of patients with paranoid schizophrenia, the efficacy of electroconvulsive therapy (ECT) combined with antipsychotics to overcome treatment resistance is demonstrated. Comparative evaluation of the results of combined therapy has allowed to establish therapeutic «targets»: the preferred use of ECT in combination with atypical antipsychotic drugs for the reduction of negative and affective symptoms, especially in the case of early onset of the disease, and ECT in combination with conventional antipsychotics - for the reduction of productive symptoms and arousal/aggression in patients with significant disease duration.
Pharmateca. 2013;(3s):59-63
pages 59-63 views

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies